1 |
Derks S, Lentjes MH, Hellebrekers DM, de Bruïne AP, Herman JG, van Engeland M : Methylation-specific PCR unraveled. Cell Oncol 26 : 291-299, 2004
|
2 |
Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R, et al. : Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 101 : 124-131, 2009
DOI
|
3 |
Eng J : Receiver operating characteristic analysis : a primer. Acad Radiol 12 : 909-916, 2005
DOI
|
4 |
Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. : Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343 : 1350-1354, 2000
DOI
|
5 |
Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, et al. : DNA methylation in glioblastoma : impact on gene expression and clinical outcome. BMC Genomics 11 : 701, 2010
DOI
|
6 |
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. : A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89 : 1827-1831, 1992
DOI
|
7 |
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 : 997-1003, 2005
DOI
|
8 |
Jung KW, Ha J, Lee SH, Won YJ, Yoo H : An updated nationwide epidemiology of primary brain tumors in republic of Korea. Brain Tumor Res Treat 1 : 16-23, 2013
DOI
|
9 |
Karayan-Tapon L, Quillien V, Guilhot J, Wager M, Fromont G, Saikali S, et al. : Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods. J Neurooncol 97 : 311-322, 2010
DOI
|
10 |
Lantos PL, Louis DN, Rosenblum Mk, Kleihues P : Tumors of the Nervous System. London : Oxford University Press, 2002.
|
11 |
Lee SH, Hwang TS, Koh YC, Kim WY, Han HS, Kim WS, et al. : A consideration of MGMT gene promotor methylation analysis for glioblastoma using methylation-specific polymerase chain reaction and pyrosequencing. Korean J Pathol 45 : 21-29, 2011
DOI
|
12 |
Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. : Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60 : 5954-5958, 2000
|
13 |
Marsh S : Pyrosequencing applications. Methods Mol Biol 373 : 15-24, 2007
|
14 |
Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, Schramm J, et al. : Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 9 : 368-381, 2007
DOI
|
15 |
Park JW, Hwang JH : The long-term survival in patients with anaplastic astrocytoma or glioblastoma. J Korean Neurosurg Soc 34 : 514-520, 2003
|
16 |
Provenzale JM, Ison C, Delong D : Bidimensional measurements in brain tumors : assessment of interobserver variability. AJR Am J Roentgenol 193 : W515-W522, 2009
DOI
|
17 |
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB : Methylation-specific PCR : a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 : 9821-9826, 1996
DOI
|
18 |
Singer-Sam J, Grant M, LeBon JM, Okuyama K, Chapman V, Monk M, et al. : Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol 10 : 4987-4989, 1990
DOI
|
19 |
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. : Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10 : 459-466, 2009
DOI
|
20 |
Verbeek B, Southgate TD, Gilham DE, Margison GP : O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy. Br Med Bull 85 : 17-33, 2008
DOI
|
21 |
Watts GS, Pieper RO, Costello JF, Peng YM, Dalton WS, Futscher BW : Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 17 : 5612-5619, 1997
DOI
|
22 |
Vlassenbroeck I, Califice S, Diserens AC, Migliavacca E, Straub J, Di Stefano I, et al. : Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma. J Mol Diagn 10 : 332-337, 2008
DOI
|